Showing results (21-30 of 51) with videos related to

Sort By:
Pageof 6
Journal of Alzheimer'S Disease : JAD|April 29, 2017
A Randomized, Double-Blind, Placebo-Controlled, Phase II Study of Oral ELND005 (scyllo-Inositol) in Young Adults with Down Syndrome without DementiaMichael S Rafii, Brian G Skotko, Mary Ellen McDonough, et al.
Journal of Alzheimer'S Disease : JAD|June 15, 2014
Synaptophysin and synaptojanin-1 in Down syndrome are differentially affected by Alzheimer's diseaseSarah B Martin, Amy L S Dowling, Joann Lianekhammy, et al.
Journal of Alzheimer'S Disease : JAD|December 17, 2016
Down Syndrome, Partial Trisomy 21, and Absence of Alzheimer's Disease: The Role of APPEric Doran, David Keator, Elizabeth Head, et al.
Journal of Alzheimer'S Disease : JAD|November 2, 2016
Metabolic and Growth Rate Alterations in Lymphoblastic Cell Lines Discriminate Between Down Syndrome and Alzheimer's DiseasePinar Coskun, Pablo Helguera, Zahra Nemati, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|November 10, 2021
Impact of increased APP gene dose in Down syndrome and the Dp16 mouse modelMariko Sawa, Cassia Overk, Ann Becker, et al.
Translational Psychiatry|April 4, 2023
Increased plasma DYRK1A with aging may protect against neurodegenerative diseasesJean M Delabar, Julien Lagarde, Marta Fructuoso, et al.
Neurobiology of Aging|April 8, 2017
Down syndrome: age-dependence of PiB binding in postmortem frontal cortex across the lifespanHarry LeVine, H Peter Spielmann, Sergey Matveev, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|August 23, 2025
Alzheimer's Disease Research Center Down Syndrome Cores: Experience from two sitesLauren Ptomey, Christy Hom, Heather Wilkins, et al.
Acta Neuropathologica|February 9, 2019
Frontal cortex and striatal cellular and molecular pathobiology in individuals with Down syndrome with and without dementiaSylvia E Perez, Jennifer C Miguel, Bin He, et al.
Pageof 6